Literature DB >> 7731963

Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice.

M Wakamiya1, M R Blackburn, R Jurecic, M J McArthur, R S Geske, J Cartwright, K Mitani, S Vaishnav, J W Belmont, R E Kellems.   

Abstract

We have generated mice with a null mutation at the Ada locus, which encodes the purine catabolic enzyme adenosine deaminase (ADA, EC 3.5.4.4). ADA-deficient fetuses exhibited hepatocellular impairment and died perinatally. Their lymphoid tissues were not largely affected. Accumulation of ADA substrates was detectable in ADA-deficient conceptuses as early as 12.5 days postcoitum, dramatically increasing during late in utero development, and is the likely cause of liver damage and fetal death. The results presented here demonstrate that ADA is important for the homeostatic maintenance of purines in mice.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7731963      PMCID: PMC42023          DOI: 10.1073/pnas.92.9.3673

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells.

Authors:  K R Thomas; M R Capecchi
Journal:  Cell       Date:  1987-11-06       Impact factor: 41.582

2.  Apparent suicide inactivation of human lymphoblast S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine and adenine arabinoside. A basis for direct toxic effects of analogs of adenosine.

Authors:  M S Hershfield
Journal:  J Biol Chem       Date:  1979-01-10       Impact factor: 5.157

3.  Differences in deoxyadenosine metabolism in human and mouse lymphocytes.

Authors:  D A Carson; J Kaye; D B Wasson
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

4.  A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice.

Authors:  M R Kuehn; A Bradley; E J Robertson; M J Evans
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

5.  Pathologic findings in adenosine deaminase deficient-severe combined immunodeficiency. II. Thymus, spleen, lymph node, and gastrointestinal tract lymphoid tissue alterations.

Authors:  H Ratech; R Hirschhorn; M A Greco
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

6.  Pathologic findings in adenosine deaminase-deficient severe combined immunodeficiency. I. Kidney, adrenal, and chondro-osseous tissue alterations.

Authors:  H Ratech; M A Greco; G Gallo; D L Rimoin; H Kamino; R Hirschhorn
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

7.  Activation of apoptosis in early mouse embryos by 2'-deoxyadenosine exposure.

Authors:  X Gao; M R Blackburn; T B Knudsen
Journal:  Teratology       Date:  1994-01

8.  Prenatal diagnosis of three cases of severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency.

Authors:  D C Linch; R J Levinsky; C H Rodeck; K A Maclennan; H A Simmonds
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

9.  Prenatal detection of a probable heterozygote for ADA deficiency and severe combined immunodeficiency disease using a microradioassay.

Authors:  D A Aitken; W J Kleijer; M F Niermeijer; E Herbschleb-Voogt; H Galjaard
Journal:  Clin Genet       Date:  1980-04       Impact factor: 4.438

10.  A micromethod for determining adenosine deaminase and purine nucleoside phosphorylase activity in cells from human peripheral blood.

Authors:  M B van der Weyden; L Bailey
Journal:  Clin Chim Acta       Date:  1978-01-02       Impact factor: 3.786

View more
  50 in total

1.  Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses.

Authors:  B A Conlon; W R Law
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

2.  Adenosine deaminase deficient severe combined immunodeficiency presenting as atypical haemolytic uraemic syndrome.

Authors:  Olga Nikolajeva; Austen Worth; Rosie Hague; Nuria Martinez-Alier; Joanne Smart; Stuart Adams; E Graham Davies; H Bobby Gaspar
Journal:  J Clin Immunol       Date:  2015-04-15       Impact factor: 8.317

3.  Point mutations at the purine nucleoside phosphorylase locus impair thymocyte differentiation in the mouse.

Authors:  F F Snyder; J P Jenuth; E R Mably; R K Mangat
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Adenosine deaminase deficiency: unanticipated benefits from the study of a rare immunodeficiency.

Authors:  Michael R Blackburn; Linda F Thompson
Journal:  J Immunol       Date:  2012-02-01       Impact factor: 5.422

Review 5.  Gene disruption in mice: models of development and disease.

Authors:  B S Shastry
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

6.  Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension.

Authors:  Harry Karmouty-Quintana; Kemly Philip; Luis F Acero; Ning-Yuan Chen; Tingting Weng; Jose G Molina; Fayong Luo; Jonathan Davies; Ngoc-Bao Le; Isabelle Bunge; Kelly A Volcik; Thanh-Thuy T Le; Richard A Johnston; Yang Xia; Holger K Eltzschig; Michael R Blackburn
Journal:  FASEB J       Date:  2014-10-15       Impact factor: 5.191

7.  Distribution of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography study.

Authors:  S Lindemalm; J Liliemark; B S Larsson; F Albertioni
Journal:  Med Oncol       Date:  1999-12       Impact factor: 3.064

8.  Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation.

Authors:  C Justin Van De Wiele; James G Vaughn; Michael R Blackburn; Catherine A Ledent; Marlene Jacobson; Hong Jiang; Linda F Thompson
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Adenine phosphoribosyltransferase-deficient mice develop 2,8-dihydroxyadenine nephrolithiasis.

Authors:  S J Engle; M G Stockelman; J Chen; G Boivin; M N Yum; P M Davies; M Y Ying; A Sahota; H A Simmonds; P J Stambrook; J A Tischfield
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

10.  Neonatal bone marrow transplantation of ADA-deficient SCID mice results in immunologic reconstitution despite low levels of engraftment and an absence of selective donor T lymphoid expansion.

Authors:  Denise A Carbonaro; Xiangyang Jin; Daniel Cotoi; Tiejuan Mi; Xiao-Jin Yu; Dianne C Skelton; Frederick Dorey; Rodney E Kellems; Michael R Blackburn; Donald B Kohn
Journal:  Blood       Date:  2008-03-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.